Cambridge Investment Research Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,482	Closed	-$202K	–	3586
2024 Q4	$202K	Buy	+1,482	New	+$202K	﹤0.01%	3190
2024 Q3	–	Sell	-2,549	Closed	-$351K	–	3490
2024 Q2	$351K	Buy	2,549 +77	+3%	+$10.6K	﹤0.01%	2578
2024 Q1	$341K	Buy	+2,472	New	+$341K	﹤0.01%	2601